{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:34:10Z","timestamp":1771626850165,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13181-020-00796-2","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T05:31:30Z","timestamp":1594531890000},"page":"465-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Persistent Hyperinsulinemia Following High-Dose Insulin Therapy: A Case Report"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1213-0411","authenticated-orcid":false,"given":"Justin N.","family":"Corcoran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine J.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis D.","family":"Olives","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey A.","family":"Bangh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon B.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"key":"796_CR1","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/15563650.2018.1533727","volume":"56","author":"DD Gummin","year":"2018","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol. 2018;56:1213\u2013415.","journal-title":"Clin Toxicol"},{"key":"796_CR2","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1097\/CCM.0000000000002087","volume":"45","author":"M St-Onge","year":"2017","unstructured":"St-Onge M, Anseeuw K, Cantrell FL, et al. Experts consensus recommendations for the management of calcium channel blocker poisoning in adults. Crit Care Med. 2017;45:e306\u201315.","journal-title":"Crit Care Med"},{"issue":"2","key":"796_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s13181-020-00758-8","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole JB, Corcoran JN, Engebretsen KM, Stellpflug SJ. Use of a porcine model to evaluate the risks and benefits of vasopressors in propranolol poisoning. J Med Toxicol. 2020;16(2):212\u201321.","journal-title":"J Med Toxicol"},{"key":"796_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/15563650.2019.1580372","volume":"57","author":"KG Katzung","year":"2019","unstructured":"Katzung KG, Leroy JM, Boley SP, Stellpflug SJ, Holger JS, Engebretsen KM. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock. Clin Toxicol. 2019;57:1073\u20139.","journal-title":"Clin Toxicol"},{"key":"796_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.ajem.2018.02.004","volume":"36","author":"JB Cole","year":"2018","unstructured":"Cole JB, Arens AM, Laes JR, Klein LR, Bangh SA, Olives TD. High dose insulin for beta-blocker and calcium channel-blocker poisoning. Am J Emerg Med. 2018;36:1817\u201324.","journal-title":"Am J Emerg Med"},{"key":"796_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/15563650.2017.1391391","volume":"56","author":"CB Page","year":"2018","unstructured":"Page CB, Ryan NM, Isbister GK. The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity. Clin Toxicol. 2018;56:389\u201396.","journal-title":"Clin Toxicol"},{"key":"796_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/15563650.2013.770152","volume":"51","author":"JB Cole","year":"2013","unstructured":"Cole JB, Stellpflug SJ, Ellsworth H, Anderson CP, Adams AB, Engebretsen KM, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol. 2013;51:201\u20137.","journal-title":"Clin Toxicol"},{"key":"796_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1080\/15563650701285412","volume":"45","author":"JS Holger","year":"2007","unstructured":"Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin Toxicol Phila Pa. 2007;45:396\u2013401.","journal-title":"Clin Toxicol Phila Pa"},{"key":"796_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3109\/15563650.2010.521753","volume":"48","author":"KM Engebretsen","year":"2010","unstructured":"Engebretsen KM, Morgan MW, Stellpflug SJ, Cole JB, Anderson CP. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol. 2010;48:806\u201312.","journal-title":"Clin Toxicol"},{"key":"796_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3109\/15563650.2014.965827","volume":"52","author":"M St-Onge","year":"2014","unstructured":"St-Onge M, Dub\u00e9 P-A, Gosselin S, et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol Phila Pa. 2014;52:926\u201344.","journal-title":"Clin Toxicol Phila Pa"},{"key":"796_CR11","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1172\/JCI105685","volume":"46","author":"MJ Perley","year":"1967","unstructured":"Perley MJ, Kipnis DM. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects*. J Clin Invest. 1967;46:1954\u201362.","journal-title":"J Clin Invest"},{"key":"796_CR12","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1073\/pnas.75.10.5173","volume":"75","author":"RA DeFronzo","year":"1978","unstructured":"DeFronzo RA, Ferrannini E, Hendler R, Wahren J, Felig P. Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A. 1978;75:5173\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"796_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3181\/00379727-126-43434","volume":"126","author":"T Tomasi","year":"1967","unstructured":"Tomasi T, Sledz D, Wales JK, Recant L. Insulin half-life in normal and diabetic subjects. Exp Biol Med. 1967;126:315\u20137.","journal-title":"Exp Biol Med"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13181-020-00796-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-020-00796-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T23:06:31Z","timestamp":1625958391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13181-020-00796-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s13181-020-00796-2","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,11]]},"assertion":[{"value":"18 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Consent for publication of this case was obtained and provided to the journal in accordance with JMT policy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}